According to a recent analysis that integrates epidemiological and genomic data to provide real-world estimates for the overall proportion of US cancer patients who harbor a coding exonic mutation in each gene, ARID1A is among the ten most commonly mutated driver genes, highlighting the role of epigenetic dysregulation in cancer [30]. This evidence concerns the gene ARID1A and cancer.